Locations:
SearchA patient’s mental preparedness counts
Often, a cancer diagnosis imparts a sense of urgency — a desire on the part of the patient to begin treatment as soon as possible, to vanquish their disease and resume a normal life.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
But what does a physician do when a patient isn’t ready?
In his latest New York Times column, Cleveland Clinic hematologist/oncologist Mikkael Sekeres, MD, MS, recounts how he responded to a patient who was hesitant about starting chemotherapy
Read the full column here.
Dr. Sekeres, Director of Cleveland Clinic Cancer Center’s Leukemia Program and Vice-chair for Clinical Research, writes regularly for the Times and other publications about his experiences as an oncologist. You can follow him on Twitter @MikkaelSekeres.
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust